Dihydroorotate dehydrogenase is a target for the biological effects of leflunomide - PubMed (original) (raw)
. 1996 Dec;28(6):3088-91.
C M Yea, P A Robson, A P Curnock, S Gadher, A B Hambleton, K Woodward, J M Bruneau, P Hambleton, S Spinella-Jaegle, P Morand, O Courtin, C Sautés, R Westwood, T Hercend, E A Kuo, E Ruuth
Affiliations
- PMID: 8962196
Dihydroorotate dehydrogenase is a target for the biological effects of leflunomide
R A Williamson et al. Transplant Proc. 1996 Dec.
No abstract available
Similar articles
- Mechanism of action of leflunomide: in vivo uridine administration reverses its inhibition of lymphocyte proliferation.
Silva HT, Cao W, Shorthouse R, Morris RE. Silva HT, et al. Transplant Proc. 1996 Dec;28(6):3082-4. Transplant Proc. 1996. PMID: 8962193 No abstract available. - The immunosuppressant leflunomide inhibits lymphocyte proliferation by inhibiting pyrimidine biosynthesis.
Cherwinski HM, Cohn RG, Cheung P, Webster DJ, Xu YZ, Caulfield JP, Young JM, Nakano G, Ransom JT. Cherwinski HM, et al. J Pharmacol Exp Ther. 1995 Nov;275(2):1043-9. J Pharmacol Exp Ther. 1995. PMID: 7473131 - In vitro and in vivo effects of leflunomide, brequinar, and cyclosporine on pyrimidine biosynthesis.
Silva HT Jr, Cao W, Shorthouse RA, Löffler M, Morris RE. Silva HT Jr, et al. Transplant Proc. 1997 Feb-Mar;29(1-2):1292-3. doi: 10.1016/s0041-1345(96)00523-4. Transplant Proc. 1997. PMID: 9123312 No abstract available. - Mechanism of action of leflunomide in rheumatoid arthritis.
Fox RI. Fox RI. J Rheumatol Suppl. 1998 Jul;53:20-6. J Rheumatol Suppl. 1998. PMID: 9666414 Review. - Dihydroorotate dehydrogenase. Profile of a novel target for antiproliferative and immunosuppressive drugs.
Löffler M, Grein K, Knecht W, Klein A, Bergjohann U. Löffler M, et al. Adv Exp Med Biol. 1998;431:507-13. Adv Exp Med Biol. 1998. PMID: 9598119 Review. No abstract available.
Cited by
- Anti-CMV therapy, what next? A systematic review.
Gourin C, Alain S, Hantz S. Gourin C, et al. Front Microbiol. 2023 Nov 20;14:1321116. doi: 10.3389/fmicb.2023.1321116. eCollection 2023. Front Microbiol. 2023. PMID: 38053548 Free PMC article. Review. - Discovery of potential natural dihydroorotate dehydrogenase inhibitors and their synergism with brequinar via integrated molecular docking, dynamic simulations and in vitro approach.
Khairy A, Hammoda HM, Celik I, Zaatout HH, Ibrahim RS. Khairy A, et al. Sci Rep. 2022 Nov 9;12(1):19037. doi: 10.1038/s41598-022-23006-1. Sci Rep. 2022. PMID: 36351991 Free PMC article. - Inhibition of porcine epidemic diarrhea virus (PEDV) replication by A77 1726 through targeting JAK and Src tyrosine kinases.
Li X, Sun J, Prinz RA, Liu X, Xu X. Li X, et al. Virology. 2020 Dec;551:75-83. doi: 10.1016/j.virol.2020.06.009. Epub 2020 Jun 18. Virology. 2020. PMID: 32829915 Free PMC article. - Control of hyperglycemia in male mice by leflunomide: mechanisms of action.
Chen J, Sun J, Doscas ME, Ye J, Williamson AJ, Li Y, Li Y, Prinz RA, Xu X. Chen J, et al. J Endocrinol. 2018 Apr;237(1):43-58. doi: 10.1530/JOE-17-0536. J Endocrinol. 2018. PMID: 29496905 Free PMC article. - Inhibition of p70 S6 kinase (S6K1) activity by A77 1726, the active metabolite of leflunomide, induces autophagy through TAK1-mediated AMPK and JNK activation.
Xu X, Sun J, Song R, Doscas ME, Williamson AJ, Zhou J, Sun J, Jiao X, Liu X, Li Y. Xu X, et al. Oncotarget. 2017 May 2;8(18):30438-30454. doi: 10.18632/oncotarget.16737. Oncotarget. 2017. PMID: 28389629 Free PMC article.